Etiology and Incidence of Moderate-to-Severe Diarrhea in Young Children in Niger

被引:13
|
作者
Platts-Mills, James A. [1 ]
Houpt, Eric R. [1 ]
Liu, Jie [1 ]
Zhang, Jixian [1 ]
Guindo, Ousmane [2 ]
Sayinzoga-Makombe, Nathan [2 ]
McMurry, Timothy L. [3 ]
Elwood, Sarah [1 ]
Langendorf, Celine [4 ]
Grais, Rebecca F. [4 ]
Isanaka, Sheila [4 ,5 ,6 ]
机构
[1] Univ Virginia, Div Infect Dis & Int Hlth, POB 801340, Charlottesville, VA 22908 USA
[2] Epictr, Niamey, Niger
[3] Univ Virginia, Dept Publ Hlth Sci, Charlottesville, VA USA
[4] Epictr, Dept Res, Paris, France
[5] Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA USA
[6] Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA USA
基金
比尔及梅琳达.盖茨基金会;
关键词
children; Cryptosporidium; diarrhea; rotavirus; Shigella; ROTAVIRUS VACCINE; SEASONALITY; EFFICACY;
D O I
10.1093/jpids/piab080
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background. High-resolution data on the etiology of childhood diarrhea in countries with the highest burden and mortality remain sparse and are needed to inform burden estimates and prioritize interventions. Methods. We tested stool specimens collected between October 2014 and December 2017 from children under 2 years of age from the per-protocol population of a placebo-controlled clinical trial of a bovine rotavirus pentavalent vaccine (Rotasiil) in Niger. We tested 1729 episodes of moderate-to-severe diarrhea (Vesikari score >= 7) using quantitative PCR and estimated pathogen-specific burdens by age, season, severity, and trial intervention arm. Results. The 4 pathogens with the highest attributable incidence of diarrhea were Shigella (7.2 attributable episodes per 100 child-years; 95% confidence interval: 5.2, 9.7), Cryptosporidium (6.5; 5.8, 7.2), rotavirus (6.4; 5.9, 6.7), and heat-stabile toxinproducing enterotoxigenic Escherichia coli (ST-ETEC) (6.2; 3.1, 7.7). Cryptosporidium was the leading etiology of severe diarrhea (Vesikari score >= 11) and diarrhea requiring hospitalization. Shigella was the leading etiology of diarrhea in children 12-23 months of age but also had a substantial burden in the first year of life, with 60.5% of episodes of severe shigellosis occurring in infants. Shigella, Cryptosporidium, and ST-ETEC incidence peaked during the warmer and wetter period and coincided with peak all-cause diarrhea incidence. Conclusions. In this high-burden setting, the leading diarrheal pathogens were Shigella, Cryptosporidium, rotavirus, and ST-ETEC, and each was disproportionately seen in infants. Vaccine development should target these pathogens, and the impact of vaccine schedule on diarrhea burden in the youngest children will need to be considered.
引用
收藏
页码:1062 / 1070
页数:9
相关论文
共 50 条
  • [21] Etiology of diarrhea by multiplex polymerase chain reaction among young children in the United Arab Emirates: a case-control study
    Alsuwaidi, Ahmed R.
    Al Dhaheri, Klaithem
    Al Hamad, Sania
    George, Junu
    Ibrahim, Judy
    Ghatasheh, Ghassan
    Issa, Mohammed
    Al-Hammadi, Suleiman
    Narchi, Hassib
    BMC INFECTIOUS DISEASES, 2021, 21 (01)
  • [22] Risankizumab in moderate-to-severe plaque psoriasis
    Serrano, Linda
    Maloney, Victoria
    Gordon, Kenneth B.
    IMMUNOTHERAPY, 2019, 11 (16) : 1357 - 1370
  • [23] Managing Moderate-to-Severe Psoriasis in the Elderly
    Balato, Nicola
    Patruno, Cataldo
    Napolitano, Maddalena
    Patri, Angela
    Ayala, Fabio
    Scarpa, Raffaele
    DRUGS & AGING, 2014, 31 (04) : 233 - 238
  • [24] The Incidence of Cryptosporidium Infection in Children with Diarrhea
    Karli, Arzu
    Metin, Ayse
    Ergen, Saime
    Simsir, Hande
    Kose, Gulsen
    JOURNAL OF PEDIATRIC INFECTION, 2013, 7 (03): : 92 - 96
  • [25] Characteristics and outcomes of critically ill children with moderate-to-severe traumatic brain injury
    Géanne Krabben-de Vlaam
    Hilde D. Mulder
    Sandra K. Dijkstra
    Johannes G. M. Burgerhof
    Martin C. J. Kneyber
    Intensive Care Medicine – Paediatric and Neonatal, 2 (1):
  • [26] Efficacy and safety of omalizumab in children with moderate-to-severe asthma: a meta-analysis
    Fu, Zhuo
    Xu, Yongsheng
    Cai, Chunquan
    JOURNAL OF ASTHMA, 2021, 58 (10) : 1350 - 1358
  • [27] The combination of nebulized sodium cromoglycate and salbutamol in the treatment of moderate-to-severe asthma in children
    Furusho, K
    Nishikawa, K
    Sasaki, S
    Akasaka, T
    Arita, M
    Edwards, A
    PEDIATRIC ALLERGY AND IMMUNOLOGY, 2002, 13 (03) : 209 - 216
  • [28] Efficacy and safety of tiotropium in school-age children with moderate-to-severe symptomatic asthma: A systematic review
    Rodrigo, Gustavo J.
    Neffen, Hugo
    PEDIATRIC ALLERGY AND IMMUNOLOGY, 2017, 28 (06) : 573 - 578
  • [29] Dupilumab efficacy in children with uncontrolled, moderate-to-severe asthma with and without an allergic phenotype
    Papadopoulos, Nikolaos
    Szefler, Stanley J.
    Bacharier, Leonard B.
    Maspero, Jorge F.
    Domingo, Christian
    Daizadeh, Nadia
    Lederer, David J.
    Hardin, Megan
    Jacob-Nara, Juby A.
    Deniz, Yamo
    Gall, Rebecca
    Ortiz, Benjamin
    Djandji, Michel
    Rowe, Paul
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [30] Psoriasiform dermatitis during dupilumab treatment for moderate-to-severe atopic dermatitis in children
    Parker, Jennifer J.
    Sugarman, Jeffrey L.
    Silverberg, Nanette B.
    Gonzalez, Mercedes Elena
    Ramien, Michele L.
    Teng, Joyce M. C.
    Paller, Amy S.
    PEDIATRIC DERMATOLOGY, 2021, 38 (06) : 1500 - 1505